(Q31064781)

28 June 2017

title

International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey (English)

1 reference

28 June 2017

1 reference

5

Michel Komajda

1 reference

28 June 2017

6

Karl Swedberg

1 reference

28 June 2017

1

Mitja Lainscak

1 reference

28 June 2017

2

John G F Cleland

1 reference

28 June 2017

Mattie J Lenzen

3

1 reference

28 June 2017

Ferenc Follath

series ordinal

4

1 reference

28 June 2017

publication date

4 October 2006

1 reference

European Journal of Heart Failure

28 June 2017

published in

1 reference

28 June 2017

volume

9

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

292-299

1 reference

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

The heart failure epidemic: exactly how big is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Is the prognosis of heart failure improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

The management of patients with heart failure in a Slovenian community hospital: what has changed between 1997 and 2000?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Demographics and concomitant disorders in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Recognising the limits of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Pharmacotherapy for heart failure in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.07.007

10.1016/J.EJHEART.2006.07.007

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference